Table 1.
Characteristic | Variable | Total, No. (%) |
---|---|---|
Age (n = 29519) | <2 y | 10100 (34.2) |
2–4 y | 10575 (35.8) | |
5–9 y | 5477 (18.6) | |
10–14 y | 3367 (11.4) | |
Sex (n = 29519) | Male | 14885 (50.4) |
Female | 14634 (49.6) | |
Type of treatment (n = 29519) | New | 28701 (97.2) |
Re-treatment | 818 (2.8) | |
Smear status (n = 3839) | Positive | 2243 (58.4) |
Negative | 1596 (41.6) | |
Site of TB disease (n = 29518) | PTB alone | 27229 (92.3) |
Any EPTB | 2289 (7.8) | |
Disease type (n = 29487) | Primary | 23437 (79.5) |
Nonprimary | 6050 (20.5) | |
HIV status (n = 29519) | Positive | 3143 (10.7) |
Negative | 13162 (44.6) | |
Unknowna | 13214 (44.8) | |
Year of TB treatment (n = 29519) | 2005 | 3519 (11.9) |
2006 | 3825 (13) | |
2007 | 3784 (12.8) | |
2008 | 4132 (14) | |
2009 | 4110 (13.9) | |
2010 | 4319 (14.6) | |
2011 | 3928 (13.3) | |
2012b | 1902 (6.4) | |
Treatment outcome 1 (n = 28318) | Cured/completed | 25353 (89.5) |
Died | 203 (0.7) | |
Moved/transferred | 932 (3.3) | |
Lost to follow-up | 1712 (6.1) | |
Failed | 118 (0.4) | |
Treatment outcome 2c (n = 25674) | Alived | 25471 (99.2) |
Died | 203 (0.8) | |
Treatment outcome 3 (n = 29519) | Unfavorablee | 4166 (14.1) |
Favorablef | 25353 (85.9) |
Abbreviations: EPTB, extrapulmonary tuberculosis; HIV, human immunodeficiency virus; PTB, pulmonary tuberculosis; TB, tuberculosis.
aMissing data were recorded as unknown and excluded from analysis except for HIV, where HIV unknown is included as a separate category.
bYear of treatment includes only 6 months of data for 2012.
cExcludes children with unknown outcomes or those who moved, transferred, or were lost to follow-up during the course of treatment where survival status was unknown.
dAlive includes all children who were cured, completed, or failed treatment.
eAll children who failed, died, moved, transferred, were lost to follow-up, or not evaluated.
fAll children who were cured or completed treatment.